Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$Adma生物制品(ADMA)$ DEF 14A - Other definitive proxy statements Filed: 2019-07-16 AccNo: 0001193805-19-000637 Size: 322 KB 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-07-08 AccNo: 0001193805-19-000621 Size: 47 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ PRE 14A - Other preliminary proxy statements Filed: 2019-07-01 AccNo: 0001193805-19-000614 Size: 386 KB 网页链接
$Adma生物制品(ADMA)$ 8-K/A [Amend] - Current report Filed: 2019-06-12 AccNo: 0001193805-19-000569 Size: 30 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Adma生物制品(ADMA)$ 内部交易: 2019-06-06,10% Owner,Biotest Divestiture Trust ,卖出,5813954普通股, $3.75
$Adma生物制品(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-06-07 AccNo: 0001123292-19-000869 Size: 250 KB 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-06-06 AccNo: 0001193805-19-000561 Size: 3 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-06-05 AccNo: 0001193805-19-000559 Size: 28 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-05-29 AccNo: 0001193805-19-000540 Size: 50 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-05-23 AccNo: 0001193125-19-154707 Size: 65 KB 网页链接